Premature infants, especially those born with less than 1500 g, often exhibit slow overall growth. Lack of early nutritional support is an important element. The present authors describe parenteral nutritional practices in a tertiary hospital and evaluate postnatal growth of preterm infants under 32 weeks of gestational age or with a birth weight < 1500 g. For population study, we examined 431 newborn files. Their median gestational age was 29.7 weeks. Of them, 25.4% were small for gestational age (SGA). 77.5% received parenteral nutrition (PN), 54.5% of which was provided on the first day. The average time was 14.7 days. The average weight gain by the 30th day was 425 g. At discharge, 37% were <P3 and 26% were P3 - P10. By the 3rd month 20% had their weight under P3, decreasing to 10% by the 12th month. Children who initiated PN in the first 24 hours of life had significantly better weight on the 30th day of their life (p < 0.001) and in the 6th month of corrected age (p = 0.038). And they had better Body Mass Index (BMI) in the 3rd (p = 0.012) and 12th (p = 0.023) months. Despite better feeding practices, there is still significant failure in post natal growth. Early introduction of PN was associated with an improved weight gain, which suggests that nutrition that included amino acids may be critical during the first 24 hours of life.
Feeding preterm infants is a challenge because there is still much to learn. And nutrition is often limited by the management of the clinical problems of extreme prematurity. Although great efforts have been made to improve neonatal nutrition in very low birth weight (VLBW) infants, many do not receive adequate nutrient intake and thus develop extrauterine growth restriction. Parenteral nutrition (PN), which allows the infant’s requirements for growth and development to be met, is indicated in infants for whom feeding via the enteral route is impossible, inadequate, or hazardous. Despite some recommendations, insufficient alimentation and postnatal growth restriction are still frequently observed these days [
Extensive research has established that infants with very low birth weight (VLBW) are particularly vulnerable to the effects of early nutritional deficiencies. Any insufficiency or delay in early nutritional support may be deleterious and contribute to both postnatal morbidities and impaired neurodevelopmental outcomes [
The goal of nutrient supply for preterm infants is to achieve a pattern of growth that is similar to intra-uterine pattern [
The history of neonatal feeding practices has undergone many modifications. In the last few years, great attention has been given to high amino acid supply in VLBW infants from the first day of life in order to avoid catabolism, establish anabolism, achieve in utero protein accretion rates, and promote linear growth. Current scientific evidence highlights the importance of supplementing the premature infant with sufficient nutrients not only to improve survival, growth and neurological development, but also to secure future health and quality of life [
Although the association of an early PN and better growth in the first weeks of life has been studied by some authors, few studies report this benefit during the first year of life.
The primary objectives were to describe alimentation of neonatal nutrition in a neonatal intensive unit in the last eleven years and determine the association between neonatal parenteral nutritional practices and infants’ growth in the first year of life.
We performed a retrospective cohort study. Our data were collected based on clinical records of infants admitted to the Neonatal Unit at a Tertiary Care Hospital of Portugal between January 2002 and December 2012 with less than 32 weeks of gestational age or birth weight less than 1500 g.
The data for each eligible infant were retrospectively collected. They include gender, birth, gestational age, hospitalization diagnosis, days with PN, PN start day, PN composition (proteins, lipids and carbohydrates) on the 1st day and maximum rate. Gestational age was based on obstetrical ultrasound; intrauterine growth restriction (IUGR) was considered if birth weight under P10. Weighing was routinely performed by nurses with digital electronic scales (reading to at least the nearest 10 g). Percentiles and Z-scores of growth were determined using Fenton and Kim curves of 2013 and growth curves from WHO 2006.
Statistical analysis was done using SPSS 20.0. Categorical variables were analyzed by using χ2 for independent measures. Students’ t test was used for continuous variables. P values of <0.05 were considered significant and confidence interval of 95% was used.
Permission to conduct the study was granted by the Hospital Ethics Committee.
The study consisted 431 preterm infants admitted to the Neonatal Department between January 2002 and December 2012 with less than 32 weeks of gestational age or birth weight less than 1500 g. Baseline characteristics of the entire study population are displayed in
Baseline characteristics | Observation |
---|---|
Median of gestational age in weeks | 29.7 |
Infant Gender; N (%) | |
Male | 241 (55.9) |
Female | 190 (44.1) |
Median of birth weight in grams | 1216.3 |
Birth weight; N (%) | |
<750 | 42 (9.9) |
750 - 999 | 73 (17.2) |
1000 - 1249 | 110 (25.9) |
1250 - 1499 | 143 (33.6) |
≥1500 | 57 (13.4) |
IUGR1; N (%) | 106 (24.6) |
1IUGR = Intrauterine Growth Restriction.
Baseline characteristics | Observation |
---|---|
Total, N (%) | 334 (77.5) |
Beginning, N (%) | |
First 24 hours | 182 (54.5) |
After 24 hours | 152 (45.5) |
Duration, average in days | 14.7 |
Maximal doses of proteins, average in g/kg/day | |
<28 weeks | 3.3 |
[28 - 32] weeks | 2.9 |
≥32 weeks | 2.7 |
Maximal doses of lipids, average in g/kg/day | |
<28 weeks | 3 |
[28 - 32] weeks | 2.6 |
≥32 weeks | 2.4 |
Maximal doses of glucose, average in mg/kg/’ | |
<28 weeks | 8.6 |
[28 - 32] weeks | 8.6 |
≥32 weeks | 7.7 |
hospitals during the first hours of life. Analyzing those who received PN, we found that 54.5% started during the first 24 hours. The average duration of PN was 14.7 days. The maximal dose of proteins, lipids and glucose was stratified according to gestational age.
These infants’ average weight gain on the 30th day of their life was 425 g. Stratifying their weight on day 30 to their gestational age (
P3 and P10; 33% were between P10 and P50 and 4% between P50 - P90.
According to the objectives of the study we compared infants who started parenteral nutrition in the first 24 hours of life (Group 1: N = 182) with those who started parenteral nutrition after 24 hours of life (Group 2: N = 152). Groups like these are naturally made. It is because our institution laboratory prepares PN one time per day, so infants born after PN preparation, will only start it on the 2nd day.
Analyzing the maximal doses of proteins, lipids and glucose achieved in parenteral nutrition of both groups (
The two groups under observation displayed different proportions of complications during hospitalization. Group 1, who started PN before 24 hours of life, had significantly less infants with necrotizating enterocolitis (NEC), 3.8% vs 16.1% (p < 0.001); intraventricular hemorrhage (IVH), 7.1% vs 13.4% (p = 0.013); sepsis, 25.0% vs 45.6%, (p < 0.001) and bronchopulmonary dysplasia (BPD), 3.3% vs 11.4% (p = 0.003).
Evaluating weight gain on the 30th day of life; we found that the 1st group was associated with better weight gain: 477 g (±214) vs 355 g (±200)―p < 0.001. At discharge there were no significant differences found between the groups during our evaluation of the percentiles of weight, length and head circumference.
The follow-up during the first year of life was possible for 85% of the population submitted to PN. In the 3, 6, 9 and 12 months infants’ weight, length, head circumference, and BMI were evaluated. These records were converted to Z-score for corrected age (Graphics 1-4). In all the periods under study, the weight, length, and
PN before 24 h | PN after 24 h | p | |
---|---|---|---|
Gestational age in weeks (average ± SD) | 29.95 ± 2.19 | 29.50 ± 2.50 | 0.079 |
Birth weight in grams (average ± SD) | 1240.97 ± 286 | 1188.74 ± 306 | 0.106 |
SGA1 rate (%) | 25.7% | 24.5% | 0.752 |
1SGA = Small for Gestational Age.
PN before 24 h | PN after 24 h | p | ||
---|---|---|---|---|
Parenteral nutrition | Maximal dose of proteins (g/kg/d) | 2.77 ± 0.52 | 2.74 ± 0.71 | 0.726 |
Day of maximal dose | 6.6 ± 5.2 | 9.2 ± 9.0 | 0.002 | |
Maximal dose of lipids (g/kg/d) | 2.61 ± 0.55 | 2.64 ± 0.54 | 0.593 | |
Day of maximal dose | 6.13 ± 4.4 | 8.53 ± 7.9 | 0.003 | |
Maximal dose of glucose (mg/kg/’) | 8.47 ± 4.9 | 8.38 ± 1.9 | 0.838 | |
Day of maximal dose | 7.6 ± 6.4 | 10.8 ± 7.8 | 0.003 | |
Beginning of enteral nutrition | 2.76 ± 1.3 | 3.9 ± 3.4 | <0.001 | |
Day of exclusively enteral nutrition | 27.2 ± 26.5 | 32.3 ± 30.5 | 0.074 |
Graphic 1. Average weight z score change in the two groups from discharge to 12 months.
Graphic 2. Average length z score change in the two groups from discharge to 12 months.
Graphic 3. Average head circumference z score change in the two groups from discharge to 12 months.
Graphic 4. Average BMI z score change in the two groups from 3 to 12 months.
BMI of the 1st group had a higher Z-score. These differences were statistically significant for the weight and length of 6-month-olds and for the BMI of 3- and 6-month-olds.
The increasing survival of very low birth weight infant is still currently a challenge for the full medical team. As reported by some authors, “the chief variable in determining the weight curve of premature infant is the feeding policy” [
Of the total population only 54.5% started PN on the first day of life. In our Unit it was impossible to institute PN on the first day to all preterm infants who need it because, until now, there were no stock intravenous solutions with proteins.
The achieved maximal doses of proteins were high in preterm under 28 weeks. This was probably because these infants had prolonged PN with minimum enteral nutrition given the possibility to reach higher amounts of liquids, glucose and proteins with parenteral nutrition.
The weight growth of our population in the first 30 days of life (mean of 425 g) is according to relevant research literature [
This growth restriction observed in the first few weeks of life has consequences in the long term. As observed in
The results of our study evidence the importance of early administration of proteins in the growth of these VLBW infants. The group who started PN on the first day (Group 1) achieved better weight in all periods studied. Another interesting observation was that the infants in the first group had shorter durations of PN administration, earlier start of enteral nutrition, and earlier achievement of full enteral feeding. The group who started parenteral nutrition earlier was also associated with fewer complications (NEC, IVH, sepsis and BPD). Although these data are not sufficient to assume a cause-effect relation, it is well recognized that poor nutrition is associated with more complications [
Previous studies have examined the relationship between amino-acid delivery and weight gain [
One limitation of the study was that conclusions are drawn on the basis of retrospectively collected data. Another limitation is that it did not evaluate the role of lipids and its influence in the growth of this preterm. Although studied and understood not as much as proteins, fatty acids play a critical role in postnatal brain development [
Finally it only evaluated growth. It could be argued that growth particularly that of weight might not be the best measure of clinical outcome in nutritional studies in preterm infants. Other criteria such as status of 2-year neurodevelopment or other morbidities may be preferred, especially because of the association between poor growth and these outcomes [
In conclusion, the results of this study, although subject to some limitations, show that the use of early PN is associated with better growth in the first few weeks of life and the first 12 months. Despite the changes in alimentation, it is still difficult to achieve an optimal extra-uterine growth. These facts highlight the importance of studying the underlying causes of postnatal growth failure. Therefore, additional research efforts should be directed to ascertaining the optimum composition and optimum use of PN in preterm infants in order to achieve nutritional strategies that both improve neurodevelopmental outcome and minimize long term metabolic and cardiovascular adverse effects.
Until better strategies arise, early start of the PN is critical. It is essential to maintain better nutritional care. As reported by some studies, adherence to these practices is still not totally ensured [
ConceiçãoCosta,TeresaTorres,AndreiaTeles, (2015) Neonatal Nutrition and Later Outcomes of Very Low Birth Weight and Preterm Infants <32 Gestational Age at a Tertiary Care Hospital of Portugal. Open Journal of Pediatrics,05,190-198. doi: 10.4236/ojped.2015.53029
BMI: Body Mass Index
BPD: bronchopulmonary dysplasia
GA: Gestational age
IUGR: Intrauterine growth restriction
IVH: Intraventricular hemorrhage
NEC: Necrotizating enterocolitis
PN: Parenteral nutrition
SGA: Small for gestational age
VLBW: Very low birth weight
WHO: World Health Organization